Fencamfamine API Manufacturers

compare suppliers & get competitive offers

This product is listed at the international narcotic list. The purchase and handling are strictly ruled by national and international laws. Pharmaoffer will validate buyers and suppliers before an order can be settled.

Filters

Reset

Selected filters:

Type
Production region
Qualifications

 

 

 

To view suppliers for this material, you need to be logged in first.

 

 

 

 

 

This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.

 

 

Looking for Fencamfamine API 1209-98-9?

Description:
Here you will find a list of producers, manufacturers and traders of Fencamfamine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Fencamfamine 
Synonyms:
Fencamfamin , Fencamfamine , Fencamfaminum , Fencanfamina  
Cas Number:
1209-98-9 
DrugBank number:
DB01463 
Unique Ingredient Identifier:
NME1I5IGBK

About Fencamfamine

What makes Fencamfamin unique? Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the drug tend to rapidly develop tolerance and escalate their dose. Fencamfamin is used for treating depressive day-time fatigue, lack of concentration and lethargy. It is especially useful in patients with chronic conditions due to its favourable safety profile.

Ask the supplier for a certificate of analysis to find out more about the quality of Fencamfamin.